You searched for oral corticosteroids

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove

Post remove

Last 6 months remove

Your search for oral corticosteroids returned 9 results

Sort Results:

Relevant Recent

ACAAI 2022

Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma

November 21, 2022

The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.

ACAAI 2022

Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab

November 16, 2022

Investigators assessed the annualized asthma exacerbation rate (AAER) and the annualized rate of asthma exacerbations requiring hospitalization over 52 weeks.

CHEST 2022

Dupilumab Reduces Oral Corticosteroid Use in OCS-Dependent Severe Asthma

October 19, 2022

Post hoc analysis of the VENTURE/TRAVERSE trials assessed dupilumab efficacy in patients with severe asthma requiring varying levels of oral corticosteroids at baseline.

CHEST 2022, News

Switching or Stopping Biologic Therapy in Severe Asthma Yields Worse Outcomes

October 18, 2022

The CLEAR study compared clinical outcomes and health resource usage in patients with severe asthma who continued, switched, or stopped their biologic treatment.

CHEST 2022

ICS-LABA Proved Effective in Treating Sjogren Syndrome With Bronchiolitis

October 18, 2022

Investigators explored the value of treating patients with bronchiolitis in primary Sjogren’s Syndrome using inhaled corticosteroids and long-acting beta agonists.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

CHEST 2022

Tezepelumab Improves Severe Asthma Even in Those Using Multiple Controllers

October 17, 2022

A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.

News

Treatment Needs Often Unmet for Generalized Pustular Psoriasis

August 15, 2022

Patients with flares more likely to have inpatient, emergency department visits

News

OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained

July 25, 2022

Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab